US 11464774
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
granted A61KA61K31/282A61K31/4965
Quick answer
US patent 11464774 (Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/282, A61K31/4965, A61K31/497, A61K31/519